Ambalal Sarabhai Enterprises Ltd
BSE:500009
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ambalal Sarabhai Enterprises Ltd
Depreciation & Amortization
Ambalal Sarabhai Enterprises Ltd
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Ambalal Sarabhai Enterprises Ltd
BSE:500009
|
Depreciation & Amortization
₹39.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Depreciation & Amortization
₹19.1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Depreciation & Amortization
₹11.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Depreciation & Amortization
₹27.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Depreciation & Amortization
₹12.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Depreciation & Amortization
₹8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Ambalal Sarabhai Enterprises Ltd
Glance View
Ambalal Sarabhai Enterprises Ltd. is a pharmaceutical and electrical holding company, which engages in the manufacture and trade of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparation (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in oncology, infertility and uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Private Limited is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited is a manufacturer of analytical and test and measuring instruments distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited and Sarabhai M Chemicals Limited, among others.
See Also
What is Ambalal Sarabhai Enterprises Ltd's Depreciation & Amortization?
Depreciation & Amortization
39.5m
INR
Based on the financial report for Dec 31, 2025, Ambalal Sarabhai Enterprises Ltd's Depreciation & Amortization amounts to 39.5m INR.
What is Ambalal Sarabhai Enterprises Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
7%
Over the last year, the Depreciation & Amortization growth was 17%. The average annual Depreciation & Amortization growth rates for Ambalal Sarabhai Enterprises Ltd have been 18% over the past three years , 7% over the past five years .
